4.6 Letter

The impact of Tween 20 on repeatability of amyloid β and tau measurements in cerebrospinal fluid

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

Stephen Salloway et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Article Clinical Neurology

Amyloid-beta 42 adsorption following serial tube transfer

Jamie Toombs et al.

ALZHEIMERS RESEARCH & THERAPY (2014)

Article Medical Laboratory Technology

Identification of an important potential confound in CSF AD studies: aliquot volume

Jamie Toombs et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2013)

Review Clinical Neurology

Dominantly Inherited Alzheimer Network: facilitating research and clinical trials

Krista L. Moulder et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Review Clinical Neurology

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

Kaj Blennow et al.

NATURE REVIEWS NEUROLOGY (2010)